Synlogic Inc. named Andrew Gengos as its COO and head of corporate development.
Gengos was most recently the president and CEO of ImmunoCellular Therapeutics Ltd.
Discover more about S&P Global’s offerings
Synlogic names COO
Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise
Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises
Essential IR Insights Newsletter - Summer July-August 2023
Insight Weekly: Climate law faces hurdles; US borrowing surges; banks revise uninsured deposits
Synlogic Inc. named Andrew Gengos as its COO and head of corporate development.
Gengos was most recently the president and CEO of ImmunoCellular Therapeutics Ltd.